These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8918281)

  • 1. Mycophenolate mofetil.
    Lipsky JJ
    Lancet; 1996 Nov; 348(9038):1357-9. PubMed ID: 8918281
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.
    Hale MD; Nicholls AJ; Bullingham RE; Hené R; Hoitsma A; Squifflet JP; Weimar W; Vanrenterghem Y; Van de Woude FJ; Verpooten GA
    Clin Pharmacol Ther; 1998 Dec; 64(6):672-83. PubMed ID: 9871432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Rinsho; 2005 May; 63 Suppl 5():684-91. PubMed ID: 15954430
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil: how to further improve using an already successful drug?
    van Gelder T
    Am J Transplant; 2005 Feb; 5(2):199-200. PubMed ID: 15643976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for the transplanted kidney?
    Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycophenolate mofetil in comparison with other immunosuppressive drugs].
    Schnülle P; van der Woude FJ
    Internist (Berl); 1998 Aug; 39(8):879-86. PubMed ID: 9757398
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil for transplantation: new drug, old problems?
    Gray DW
    Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil: a promising immunosuppressive agent.
    Kulkarni AA; Shah BV
    J Assoc Physicians India; 2004 Jan; 52():33-8. PubMed ID: 15633716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report.
    Cattaneo D; Bitto A; Baldelli S; Cortinovis M; Gotti E; Perico N; Remuzzi G
    Transplantation; 2008 Mar; 85(6):921-2. PubMed ID: 18360279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation].
    Friedrich J; Erhard J
    Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil versus sirolimus as an adjunct to calcineurin inhibition after renal transplantation.
    Pavlakis M
    Nat Clin Pract Nephrol; 2006 Oct; 2(10):558-9. PubMed ID: 17003833
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
    Thervet E
    Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in Chinese kidney transplant recipients treated with mycophenolate mofetil.
    Lu YP; Lin B; Liang MZ; Wang L; Nan F; Yu Q; Tang KS
    Transplant Proc; 2004 Sep; 36(7):2079-81. PubMed ID: 15518752
    [No Abstract]   [Full Text] [Related]  

  • 20. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
    Rerolle JP; Szelag JC; Le Meur Y
    Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.